BetaPublic beta

Spending
Lobbying
Coming soon: Congress, Stocks

Spending
- Overview
- Agencies
- Programs
- Recipients
- Awards
Lobbying
Congress
Stocks

About Privacy Terms

© 2026 Adaptrex, LLC

About
Privacy
Terms

© 2026 Adaptrex, LLC

Spending
Lobbying
Coming soon: Congress, Stocks

Overview Firms Clients Revolving Door Stands Out

BIOVAIL CORPORATION — Lobbying — Receipts Report

LD-2 disclosure · 1st Quarter - Report

BIOVAIL CORPORATION

via BROWNSTEIN HYATT FARBER SCHRECK, LLP

1st Quarter (Jan 1 - Mar 31) · 2008Posted Apr 20, 2008Filing document ↗LDA record ↗

Coverage · No income or expenses were reported on this filing.

Client

Name: BIOVAIL CORPORATION
Description: Specialty pharmaceuticals
Location: United States of America

Registrant

Firm: BROWNSTEIN HYATT FARBER SCHRECK, LLP
Description: Law firm
Location: Washington, District of Columbia, United States of America

Lobbying activities

1 issue

Financial Institutions/Investments/Securities
Financial market transparency
LobbyistsNORMAN BROWNSTEIN · mr MICHAEL B LEVY · ALEXANDER DAHL · WILLIAM MOSCHELLA · KATIE STAHL · MAKAN DELAHIM · mr JAMES GERARD FLOOD
Covered position (WILLIAM MOSCHELLA): Intern - Congressman Frank Wolf
Covered position (KATIE STAHL): Legislative Intern - Senator Orrin Hatch
Covered position (MAKAN DELAHIM): Chf. Counsel & Staff Dir.-Senate Judiciary Comm.
TargetedSENATE · HOUSE OF REPRESENTATIVES · Securities & Exchange Commission (SEC)

Source

Source · Senate Office of Public Records — Lobbying Disclosure Act filings ↗.

Coverage gaps · LD-2 reports a single dollar figure per quarter on ONE basis — income (a fee) or expenses (self-filed spend), never both — so this page never combines them into one "spend" number.